---
category: news
title: "Alzheimer’s drug lecanemab has ‘moderate’ effect on cognitive decline, new trial data show"
excerpt: "The phase 3 results, published Tuesday, showed a 27% slower rate of cognitive decline in recipients ... for the Centers for Medicare & Medicaid Services, and the Alzheimer’s Association called ..."
publishedDateTime: 2022-12-01T01:03:00Z
originalUrl: "https://www.mcknights.com/news/clinical-news/alzheimers-drug-lecanemab-has-moderate-effect-on-cognitive-decline-new-trial-data-show/"
webUrl: "https://www.mcknights.com/news/clinical-news/alzheimers-drug-lecanemab-has-moderate-effect-on-cognitive-decline-new-trial-data-show/"
type: article

provider:
  name: McKnight's Long-Term Care News
  domain: mcknights.com

topics:
  - Microsoft AI
  - AI

secured: "hgQjFMnmCY4T4V9f0TmDdixLiMdertq5Lr2tuXGNiP7vCUHaJF0N34hxfDxumv+vEhEjDXl9BESepiKML83U3HbLqwhoRtwDqvobZBNdunfQnZKohdWyaEd+QM2KgIiOSXAKOmjwR/1SJ2IB6JXy54+jBgZESI0iPxhKzIIBg9C5p38n9wl/kbixIpqxufYUB7a5CobJwq3MkD9rsM/JS7eaMS9Byd9ua9WVBAvWL22yM2VWkH6XVVboLfOZBmp8LiVy5npcsH6UUwUL22sgqciL2guU5zpbHEM9PiG8gshughw7IMQmud2Q2qQeOfTVgPEYNYfCHRNQFbOsf4uUAhzjRnP0OU/oMIDvxH5FvGs=;aGOkI7NavAyVHtRqhIz6gA=="
---

